Making a Case for the Right “-Ase” in Acute Ischemic Stroke: Alteplase, Tenecteplase, and Reteplase

Expert Opinion on Drug Safety - United Kingdom
doi 10.1080/14740338.2019.1573985
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2019English

Acanthopanax for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Cerebrolysin for Acute Ischemic Stroke

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
2013English

Sonothrombolysis for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Effect of IV Alteplase on the Ischemic Brain Lesion at 24–48 Hours After Ischemic Stroke

Neurology
Neurology
2018English

Decompressive Craniectomy for Acute Ischemic Stroke

Critical Care
Critical CareIntensive Care Medicine
2019English

Hemodilution in Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1988English

Endothelins in Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1998English

Protocol for the Perfusion and Angiography Imaging Sub-Study of the Third International Stroke Trial (IST-3) of Alteplase Treatment Within Six-Hours of Acute Ischemic Stroke

International Journal of Stroke
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy